Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Other Voices: Know the difference between conviction and clarity in marketing

Monday, March 05, 2012

This article was authored by Diane Harrison, principal and owner of Panegyric Marketing, a marketing communications firm founded in 2002 that specializes in a wide range of strategy and writing services within the alternative assets sector.

As we head into the tail end of Q1 2012, an interesting conundrum has been rearing its head since this time last year. While a common theme in both 2011 and 2012 has been that the alternative industry has been growing in terms of investor interest and that investors are examining the benefits offered by these non-correlated investment options as a means of mitigating the performance and risk-based issues present in today’s equity and bond markets, the reality is that allocations have been scarce as hen’s teeth. Only a select few alternative managers, mostly large and well-known, have been reaping the rewards of this heightened interest.

Fund managers give voice to their frustration over not having success in raising capital for their funds, while allocators and investors cry out for alternative means to divert their assets from the nonperformance of traditional asset classes. “Where are the options to invest my underperforming funds?” appeals the latter, while the former vents with “I’ve had solid performance, my risk controls are tight, my operational infrastructure is in place, and I have demonstrated my abilities in the strategy for years.” So why not the conn......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for